MedPage Today on MSN
After 5 Years, Acid-Reducer Is Back on the Market
The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled ...
Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.
FDA clears reformulated ranitidine after five years, ensuring safety with new labeling and storage instructions for acid-reducing treatment.
Oakland, California, June 24, 2022 (GLOBE NEWSWIRE) -- The California State Court Judge overseeing the Ranitidine Products Cases JCCP NO. 5150 issued a pretrial order this week establishing a trial ...
A Dallas law firm is part of a team taking on some of the biggest drug-makers in a nationwide lawsuit that alleges that over-the-counter heartburn medication Zantac causes cancer. In April 2020, the ...
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Zantac 75 relief is an effective antacid that has Ranitidine as one of its chief ingredients. Ranitidine is one of the most effective antacids available in the market place and is extremely effective ...
Zantac march is also made for the treatment of post-operative ulcer, Zollinger-Ellison Diencephalon xalatan generic cost oesophageal reflux disease including even term management of healed young. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results